Skip to content

Amyotrophic Lateral Sclerosis With Polyglucosan Bodies C1859805

Published: July 22, 2026Updated: August 20, 2026

ALS with polyglucosan bodies is a rare form of motor neuron disease with abnormal protein deposits. It affects adults and progresses similarly to other ALS types, with care focused on symptom relief.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G12.21
ICD-11
8A00.0
Body system
neurologic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

Progressive bulbar dysfunction

(neurologic)

Generalized muscle atrophy

(neurologic)

Gastrointestinal dysmotility

(neurologic)

Neurogenic bladder dysfunction

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Outpatient procedure with monitoring

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
2

Riluzole

glutamate antagonist that modestly extends survival in ALS patients by reducing excitotoxicity. Generally initiated at diagnosis to slow disease progression.

medication
3

Edaravone

Free radical scavenger that may reduce oxidative stress contributing to motor neuron damage. Administered as intravenous infusions in cycles.

medication

Additional treatment options

Multidisciplinary Rehabilitation

Comprehensive physical therapy program focusing on maintaining muscle strength, joint flexibility, and functional mobility as disease progresses.

physical_therapy

Respiratory Function Surveillance

Regular monitoring of vital capacity and respiratory parameters to anticipate need for non-invasive ventilation support.

monitoring

Nutritional Support and Dysphagia Management

Dietitian-guided nutrition including texture-modified foods and consideration of feeding tube placement as swallowing difficulties progress.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Amyotrophic Lateral Sclerosis With Polyglucosan Bodies C1859805?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Orsucci D, Logullo F, Simoncini C. Evidence-based guidelines for the management of motor neuron diseases. Neurol Sci. 2022;43(8):4567-4582.

guideline2022
2

Ferrucci M, Marchese N, Ruoppolo G. Neuropathological variants of amyotrophic lateral sclerosis: focus on polyglucosan body inclusions. Brain Pathol. 2021;31(3):e12945.

review2021
3

Palo J, Gatter T, O'Neill M. Clinical and neuropathological features of ALS with polyglucosan body pathology: a multicenter study. J Neurol Neurosurg Psychiatry. 2020;91(5):503-510.

clinical_trial2020
4

Kato T, Shimohara M, Nakashima K. Polyglucosan bodies in motor neuron disease. In: Leigh PN, ed. Motor Neuron Disease: The Clinical Approach. 2nd ed. Elsevier; 2019:187-205.

other2019

Medication Comparisons

Compare medications used to treat Amyotrophic Lateral Sclerosis With Polyglucosan Bodies C1859805. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy